Nektar Therapeutics (NKTR)
(Delayed Data from NSDQ)
$1.32 USD
0.00 (0.00%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.32 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Cash flow Statements
Fiscal Year End for Nektar Therapeutics falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -276.06 | -368.20 | -523.84 | -444.44 | -440.67 |
Depreciation/Amortization & Depletion | 84.32 | 13.03 | 20.88 | 14.18 | 13.16 |
Net Change from Assets/Liabilities | -19.80 | 0.49 | -23.08 | 16.71 | 21.69 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 18.93 | 50.67 | 113.38 | 100.26 | 77.14 |
Net Cash From Operating Activities | -192.61 | -304.01 | -412.66 | -313.29 | -328.68 |
Property & Equipment | 0.38 | 7.52 | -14.99 | -7.26 | -26.29 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 139.18 | 358.32 | 217.77 | 503.47 | 233.17 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 139.56 | 365.84 | 202.78 | 496.21 | 206.89 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.03 | 0.76 | 33.24 | 23.40 | 23.36 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | -250.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.75 | 3.00 | 146.25 | 0.00 |
Net Cash from Financing Activities | 0.03 | 1.51 | 36.24 | -80.35 | 23.36 |
Effect of Exchange Rate Changes | 0.06 | -0.33 | -0.09 | 0.02 | -0.10 |
Net Change In Cash & Equivalents | -52.95 | 63.01 | -173.74 | 102.59 | -98.54 |
Cash at Beginning of Period | 88.23 | 25.22 | 198.96 | 96.36 | 194.91 |
Cash at End of Period | 35.28 | 88.23 | 25.22 | 198.96 | 96.36 |
Diluted Net EPS | -1.45 | -1.97 | -2.86 | -2.49 | -2.52 |
Fiscal Year End for Nektar Therapeutics falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -276.06 | -233.98 | -188.14 | -137.02 |
Depreciation/Amortization & Depletion | NA | 84.32 | 70.53 | 72.82 | 75.67 |
Net Change from Assets/Liabilities | NA | -19.80 | -15.07 | -10.58 | -1.52 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 18.93 | 32.96 | 22.47 | 10.95 |
Net Cash From Operating Activities | NA | -192.61 | -145.56 | -103.44 | -51.92 |
Property & Equipment | NA | 0.38 | 0.62 | -0.60 | -0.43 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 139.18 | 121.56 | 66.36 | 41.03 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 139.56 | 122.18 | 65.77 | 40.60 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.03 | 0.02 | 0.02 | 0.00 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 0.03 | 0.02 | 0.02 | 0.00 |
Effect of Exchange Rate Changes | NA | 0.06 | 0.05 | 0.15 | 0.05 |
Net Change In Cash & Equivalents | NA | -52.95 | -23.31 | -37.50 | -11.27 |
Cash at Beginning of Period | NA | 88.23 | 88.23 | 88.23 | 88.23 |
Cash at End of Period | NA | 35.28 | 64.92 | 50.73 | 76.96 |
Diluted Net EPS | NA | -0.21 | -0.24 | -0.27 | -0.73 |